View Press Releases
-
Lifebit Appoints General Manager to Spearhead Global Expansion
LONDON, UK - Sep 8, 2020 - Lifebit Biotech announced today the appointment of Frank Seo, who joins the company as General Manager
Sep 8, 2020
-
DIASORIN AND MEMED PARTNER TO DEVELOP AND COMMERCIALIZE NOVEL HOST IMMUNE RESPONSE BASED DIAGNOSTICS SOLUTION
SALUGGIA, ITALY AND HAIFA, ISRAEL - Sep 8, 2020 - DiaSorin (FTSE MIB: DIA) and MeMed have announced today the creation of a strategic partnership to accelerate the deployment of a novel, host-protein signature-based assay
Sep 8, 2020
-
First-class Chelating Agents Covering Full Range Are Available at CD Bioparticles
SHIRLEY, NY, UNITED STATES - Sep 9, 2020 - Chelating agents are chemical compounds that react with metal ions to form a stable, water-soluble complex
Sep 6, 2020
-
Creative Biolabs Introduces One-Stop CAR-T Preclinical In Vivo Assay Services
SHIRLEY, NY, UNITED STATES - Sep 7, 2020 - Chimeric antigen receptor (CAR) T cell therapy represents the culmination of research in both immunology and oncology fields
Sep 6, 2020
-
Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion
BOSTON, MA - Sep 3, 2020 - Biofourmis, a fast-growing global leader in digital therapeutics that powers personalized predictive care, has announced the completion of a $100 million Series C financing round led by SoftBank Vision Fund 2,[1] with participation by existing investors Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI
Sep 3, 2020
-
Former FDA Commissioner Dr. Scott Gottlieb to address industry on sustainable innovation at CPhI Festival of Pharma
AMSTERDAM, THE NETHERLANDS - Sep 3, 2020 - : CPhI Festival of Pharma (5-16 October, 2020), the worlds largest ever virtual pharma expo, unveils its ground-breaking two-week long agenda
Sep 3, 2020
-
Senior team at healthcare agency Page & Page become Partners
LONDON, UNITED KINGDOM - Sep 2, 2020 - Senior team at healthcare agency Page & Page become Partners Significant changes at Page & Page and Partners also include a new London office, a series of client wins and company growth during Covid London, UKx
Sep 2, 2020
-
AskBio Awarded £2m Scottish Enterprise R&D Grant to Help Reduce Barriers to Mainstream Gene Therapy Primary tabs
EDINBURGH, UNITED KINGDOM - Sep 2, 2020 - Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage gene therapy company dedicated to developing adeno-associated virus (AAV) gene therapies for genetic disorders, announces the award of a £1
Sep 2, 2020
-
FamHis, Inc. Completes its Launch of the FamGenix Family Health History Platform
BOYNTON BEACH, FL - Sep 1, 2020 - FamHis, Inc. announces the completion and worldwide release of their next-generation family health history platform FamGenix
Sep 1, 2020
-
CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management
LOUVAIN-LA-NUEVE, BELGIUM - Sep 1, 2020 - CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software for clinical trials, today announced a minority investment from Summit Partners, a global growth equity investor with $21 billion in assets under management
Sep 1, 2020
-
CD Genomics Introduces Extended Panels for SARS-CoV-2 Detection and Research
SHIRLEY, NY, UNITED STATES - Aug 28, 2020 - CD Genomics, a leader in sequencing, microarray analysis, library construction and genotyping, recently announced availability of its CDAMP® SARS-CoV-2 Panel Kit, CDCAP® β-CoVs Panel Kit and CDCAP® Respiratory Virus Panel Kit for SARS-CoV-2 detection and research via its predesigend NGS panels
Aug 27, 2020
-
Panthera further extends its network of clinical trial sites with the opening of a clinical trial site in North London in collaboration with Medicus Health Partners
PRESTON, UNITED KINGDOM - Aug 26, 2020 - Since launching its first site in Preston in North West England in 2019, Panthera continues to expand its network of UK clinical trial sites with a new site in North London in collaboration with a GP Super partnership Medicus Health Partners
Aug 26, 2020
-
Aveshka announces Dr. Til Jolly as Chief Medical Officer
WASHINGTON, DC, UNITED STATES - Aug 10, 2020 - Aveshka announced Dr. Til Jolly will join the companys executive team in the newly created role of Chief Medical Officer (CMO)
Aug 21, 2020
-
The Chemistry-Focused Technology Platform Is Optimized at Alfa Chemistry
NY, NY - Aug 19, 2020 - Alfa Chemistry, the US-located chemical supplier, has recently announced that it has finished the optimization work of its chemistry-focused technology platform, which enables the company to offer a comprehensive range of services such as synthetic chemistry, chiral separations, small molecule synthesis, peptide, nucleoside, fluorinated building blocks, milligram preparation, kilogram GLP scale-up, reagent service, and compound management
Aug 20, 2020
-
AI & Medicine Develops Medical Therapy and Research System to Facilitate Disease Treatment
NY, NY - Aug 20, 2020 - AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces that it has successfully developed a medical therapy and research system, which can assist in disease treatment, health management, adjuvant therapy, and deep mining of public document database
Aug 20, 2020
-
InSysBio to present the new version of Immune Response Template
MOSCOW, RUSSIA - Aug 20, 2020 - InSysBio, one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents the new version of its Immune Response Template (IRT)
Aug 20, 2020
-
Rho Experts Share Approach for Maximizing Benefits of Decentralized Trials During Free Webinar
DURHAM, NC, US - Aug 20, 2020 - MEDIA ADVISORYRho Experts Share Approach for Maximizing Benefits of Decentralized Trials During Free WebinarCRO shares best practices and solutions to help sponsors get the most out of their hybrid, virtual and synthetic clinical trials WHAT: Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, will discuss its approach to and solutions for maximizing the benefits of decentralized clinical trials in an upcoming webinar, "CROs: The Tip of the Spear in Maximizing the Value of Hybrid, Virtual, and Synthetic Clinical Trials
Aug 19, 2020
-
Lyniate and PatientPing Form Strategic Partnership to Ensure Compliance with the CMS E-Notifications Requirements
BOSTON, MA - Aug 19, 2020 - Lyniate, a global leader in healthcare data interoperability, today announced a partnership with PatientPing, the nations most comprehensive care collaboration platform, to develop a connector solution that provides the IT infrastructure necessary to support seamless integration of e-notification data for admissions, discharges, and transfers (ADT)
Aug 19, 2020
-
Ojai Valley Community Hospital Implements eVideon Solution to Support Patient Engagement Initiative
GRAND RAPIDS, MI - Aug 18, 2020 - eVideon, a leader in interactive patient engagement and digital workflow solutions, today announced that Ojai Valley Community Hospitals Continuing Care Center, a brand new 75-bed skilled nursing facility, has gone live with the companys market-leading Patient Experience Platform and Digital Signage solutions
Aug 18, 2020
-
Alveo Technologies Expands Leadership Team with Appointment of Julianne Averill as Chief Financial Officer
ALAMEDA, CA, UNITED STATES - Aug 18, 2020 - Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced it has appointed Julianne Averill, CPA, as Chief Financial Officer
Aug 18, 2020